- Report
- February 2024
Israel
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Ireland
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Iraq
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Iran
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Indonesia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
India
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Iceland
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Morocco
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Moldova
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Mexico
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Malta
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Malaysia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Lithuania
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Lebanon
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Latvia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Kuwait
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Kenya
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Paraguay
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Panama
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Pakistan
From €2551EUR$2,850USD£2,173GBP

Immunofixation is a type of in vitro diagnostics (IVD) used to identify and quantify monoclonal immunoglobulins and light chains in serum and urine. It is a two-step process that involves the use of antibodies to separate and identify the components of a sample. The first step involves the use of a polyclonal antibody to separate the sample into its component parts. The second step involves the use of a monoclonal antibody to identify the components of the sample. Immunofixation is used to diagnose and monitor a variety of conditions, including multiple myeloma, Waldenström's macroglobulinemia, and amyloidosis.
The Immunofixation market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for accurate and timely diagnosis. Companies in the Immunofixation market include Abbott, Bio-Rad Laboratories, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific. Show Less Read more